IKS Health Welcomes Laura Anderson as Chief Product Officer
September 03 2024 - 11:55AM
Business Wire
IKS Health, a provider of healthcare solutions, is pleased to
announce the appointment of Laura Anderson as Chief Product
Officer. With over 30 years of experience in healthcare IT, Laura
brings extensive expertise in aligning product strategies with
market needs, driving innovation, and enhancing customer value.
In her new role, Laura will be responsible for guiding the
strategic direction of IKS Health’s product roadmap, with a focus
on the continued evolution of the Care Enablement Platform. Her
leadership will ensure that the platform remains at the forefront
of industry demands, helping to deliver seamless and impactful
solutions that meet the ever-changing needs of healthcare delivery
organizations.
“Laura’s track record of leading high-performing global product
teams and her deep understanding of healthcare technology make her
an invaluable addition to our leadership team,” said Sachin Gupta,
CEO of IKS Health. “Her ability to align product development with
client needs and market trends will be instrumental as we continue
to innovate and expand our offerings. We are confident that Laura
will help us unlock new opportunities for value creation and
further strengthen our position as a leader in the healthcare
industry.”
Laura’s extensive experience includes leadership roles at Change
Healthcare, Elsevier, Optum, NextGen, and Siemens Healthcare. She
has been pivotal in advancing patient engagement, revenue
optimization, clinical workflows, clinical decision support, and
EHR systems across various healthcare technology offerings.
“I’m honored to join IKS Health at a pivotal moment in the
healthcare industry,” said Laura Anderson. “The Care Enablement
Platform is uniquely positioned to address the complex challenges
healthcare faces today. I’m excited to collaborate with the
talented team here to drive innovation and create lasting value for
our clients.”
About IKS Health
IKS Health takes on the chores of healthcare—spanning
administrative, clinical, and operational burdens—so that
clinicians can focus on their core tasks of medical care delivery.
Combining pragmatic technology and dedicated experts, IKS enables
stronger, financially sustainable enterprises. IKS’s Care
Enablement Platform delivers data-driven value and expertise across
the care journey, and IKS is a partner for clinician enterprises
looking to effectively scale, improve quality and achieve cost
savings through forward-thinking solutions. Founded in 2006, IKS’s
technology-enabled solutions and global workforce supports large
health systems, medical groups and risk bearing entities across the
United States. For more information, visit ikshealth.com.
Inventurus Knowledge Solutions Limited is proposing, subject to
receipt of requisite approvals, market conditions and other
considerations, to make an initial public offer of its equity
shares, and has filed a draft red herring prospectus (“DRHP”) with
the Securities and Exchange Board of India (“SEBI”). The DRHP is
available on the website of SEBI at www.sebi.gov.in as well as on
the websites of the book running lead managers, ICICI Securities
Limited, JM Financial Limited, J.P. Morgan India Private Limited,
Jefferies India Private Limited and Nomura Financial Advisory and
Securities (India) Private Limited, at
https://www.icicisecurities.com, https://www.jmfl.com/,
www.jpmipl.com, www.jefferies.com and
www.nomuraholdings.com/company/group/asia/india/index.html
respectively, and the websites of the stock exchange(s) at
www.nseindia.com and www.bseindia.com, respectively. Any potential
investor should note that investment in equity shares involves a
high degree of risk and for details relating to such risk, see
“Risk Factors” of the RHP, when available. Potential investors
should not rely on the DRHP for any investment decision.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240903852570/en/
Sarah Bennight SVP Marketing sarah.bennight@ikshealth.com
214-766-5967